Investment Summary |
|
|---|---|
| Date | 2025-04-17 |
| Target | Lexington Medical |
| Sector | Medical Products |
| Investor(s) | Ampersand Capital Partners |
| Deal Type | Growth Capital |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 85 of 85 |
| Sector: Medical Products M&A | 18 of 18 |
| Type: Growth Capital M&A Deals | 25 of 25 |
| State: Massachusetts M&A | 16 of 16 |
| Country: United States M&A | 70 of 70 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-12-02 |
Gannet BioChem
Huntsville, Alabama, United States Gannet BioChem is a specialty CDMO specializing in the development, scaling, and manufacturing of polyethylene glycol (PEG) reagents essential components in advanced biopharmaceutical and therapeutic products. Gannet BioChem is based in Huntsville, Alabama. |
Buy | - |
